by rdbiomed | May 26, 2020 | Company News
We’re delighted to share the news that Restech, our distribution partner in the US, has launched a branded version of our reflux diagnostic saliva test – known as ‘PepsinCheck by Peptest’. Respiratory Technology Corporation (Restech) is a leader in engineering world... 
by rdbiomed | May 22, 2020 | GERD, pepsin
Salivary pepsin could potentially be used as a non-invasive marker of reflux aspiration in children with gastro-oesophageal reflux disease (GORD) – a new study has shown. Reflux aspiration secondary to GORD/ GERD is one of the causes of chronic gastrointestinal and... 
by rdbiomed | May 18, 2020 | Company News
We’re delighted to announce that the Peptest laboratories will reopen for testing of saliva samples for pepsin on Monday 25 May. During the coronavirus pandemic we made the decision to temporarily suspend testing due to restrictions on staff movements and concerns... 
by rdbiomed | Apr 2, 2020 | reflux
Testing saliva for the stomach enzyme pepsin can help speed up the management of reflux, a new research study has concluded. Peptest – a salivary pepsin test – is also described as an ‘important diagnostic tool’ for gastro-oesophageal reflux disease (GORD/ GERD) and... 
by rdbiomed | Mar 26, 2020 | Company News
In these difficult times with the Covid-19 (Coronavirus) outbreak, to protect our staff members, the majority of the RD Biomed and Peptest team will be working from home and following all of the government guidelines for the near future. We are temporarily suspending...
Recent Comments